A detailed history of Jpmorgan Chase & CO transactions in Viemed Healthcare, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 98,798 shares of VMD stock, worth $855,590. This represents 0.0% of its overall portfolio holdings.

Number of Shares
98,798
Previous 39,260 151.65%
Holding current value
$855,590
Previous $257,000 181.71%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$6.3 - $7.6 $375,089 - $452,488
59,538 Added 151.65%
98,798 $724,000
Q2 2024

Aug 12, 2024

BUY
$6.32 - $9.38 $71,927 - $106,753
11,381 Added 40.82%
39,260 $257,000
Q1 2024

May 10, 2024

BUY
$7.29 - $9.99 $37,521 - $51,418
5,147 Added 22.64%
27,879 $262,000
Q4 2023

Feb 12, 2024

SELL
$6.04 - $8.45 $3,545 - $4,960
-587 Reduced 2.52%
22,732 $178,000
Q3 2023

Nov 14, 2023

SELL
$6.73 - $9.85 $22,222 - $32,524
-3,302 Reduced 12.4%
23,319 $156,000
Q2 2023

Aug 11, 2023

SELL
$9.2 - $11.77 $270,213 - $345,696
-29,371 Reduced 52.46%
26,621 $260,000
Q1 2023

May 11, 2023

BUY
$7.55 - $10.2 $421,599 - $569,578
55,841 Added 36980.79%
55,992 $540,000
Q3 2022

Nov 14, 2022

SELL
$5.43 - $7.96 $8,090 - $11,860
-1,490 Reduced 90.8%
151 $1,000
Q2 2022

Aug 11, 2022

SELL
$4.94 - $5.81 $96,987 - $114,067
-19,633 Reduced 92.29%
1,641 $9,000
Q1 2022

May 11, 2022

SELL
$3.58 - $5.55 $105,366 - $163,347
-29,432 Reduced 58.04%
21,274 $107,000
Q4 2021

Feb 10, 2022

SELL
$4.98 - $6.08 $171,486 - $209,364
-34,435 Reduced 40.44%
50,706 $265,000
Q3 2021

Nov 12, 2021

BUY
$5.55 - $7.4 $472,532 - $630,043
85,141 New
85,141 $472,000

Others Institutions Holding VMD

About VIEMED HEALTHCARE, INC.


  • Ticker VMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 38,222,000
  • Market Cap $331M
  • Description
  • Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, per...
More about VMD
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.